Stellar Biotechnologies, a manufacture of Keyhole Limpet Hemocyanin (KLH), has launched Stellar KLH enzyme-linked immunosorbent assay (ELISA) test kits for pharmaceutical immunotoxicology research.
Subscribe to our email newsletter
The six different kits are designed for the rapid, quantitative measure of either IgG or IgM antibodies in a range of preclinical models.
The new assay kits are the first anti-KLH ELISAs leveraging the Stellar KLH protein, the company said.
KLH can be used to assess both humoral and cellular immune responses.
Stellar Biotechnologies CEO and president Frank Oakes said: "Our goal was to apply Stellar KLH⢠technology to improve the predictive value of pharmaceutical immunotoxicology testing using higher quality, standardized products – both KLH protein and assays – not available to researchers before."